BioCentury
ARTICLE | Clinical News

Byetta exenatide endocrine data

March 30, 2009 7:00 AM UTC

Amylin Pharmaceuticals Inc. (NASDAQ:AMLN), San Diego, Calif. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Product: Byetta exenatide Business: Endocrine Molecular target: Glucagon-like peptide-1...